Navigation Links
Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
Date:8/22/2008

9,395 Women Enrolled in Trial Sponsored by Medical Research Council

LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company's candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The trial is sponsored by the United Kingdom's Medical Research Council (MRC) and conducted by the Microbicides Development Programme (MDP), an international partnership of researchers established to develop microbicides for the prevention of HIV transmission. This trial enrolled 9,395 women at clinics in South Africa, Tanzania, Uganda, and Zambia. Results from this trial are expected to be available by the end of 2009.

This is the second large trial testing the safety and effectiveness of the 0.5% dose of PRO 2000 and the largest trial of any microbicide to date. In July 2007, enrollment of 3,100 women was completed in Protocol HPTN 035 sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Results from the HPTN 035 trial are expected to be available by early 2009.

"The completion of enrollment in this trial marks a significant milestone for Indevus, our shareholders and for women who may benefit from a product that provides a female-controlled option for HIV and STD prevention," said Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "We have now completed enrollment in two pivotal trials with over 12,000 women participating. If the trials are successful, we expect to be in a position to file marketing applications with regulatory authorities, in
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Submission of New Drug Application
3. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
4. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
5. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
6. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... LAKE, N.J. and SAN DIEGO ... today that its parent company Eisai Co., Ltd. (Headquarters: ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... CEO: Dr. Helen Torley , "NASDAQ: HALO") have ... mesylate (brand name: Halaven ® , "eribulin") in combination ...
(Date:7/31/2015)... 2015 Magnaquest, a leading ... and cloud computing operators has signed a Proof ... for Internet of Things (IoT) related initiative. The ... subscription model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ... for business innovations to make healthcare services more ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... Remedi SeniorCare®, one of the nation,s largest ... innovative solution for the long-term care industry -- ... long-term care facilities to more efficiently and ... This includes complex medication orders, electronic health ...
... 2012 Span-America Medical Systems, Inc. (NASDAQ:  SPAN) will ... conference call on Friday, February 3, 2012, covering results ... released after the regular close of trading the preceding ... call will be available online at www.spanamerica.com ...
Cached Medicine Technology:Connexit™ Launch Aims to Reshape Business of Long-Term Care 2Connexit™ Launch Aims to Reshape Business of Long-Term Care 3
(Date:7/31/2015)... ... ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened a ... July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and Latin ... Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... currently going on in Chicago at Grant Park. The festival will end on ... North America to Chicago for the annual Lollapalooza. This unique and unbelievably popular ...
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... ... five new industry players to know in predictive health analytics , Jvion ... learning technologies. The firm creates predictive software that targets patient and population level ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride ... in Downtown Memphis on October 3, 2015. The Ride to Fight On is a ... research between Methodist Healthcare, The West Clinic and The University of Tennessee Health Science ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy the summer ... to cook the next meal, making July the most appropriate to be National Hot ... and recipes. , Make the next cookout different than the ones in the past. ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... , DURHAM, N.C., Sept. 22 Oxygen Biotherapeutics, ... Chris Stern, will present at an investor conferences in Zurich on Sept. ... the Zurich Airport Radisson Hotel and is scheduled for 7:00 p.m. The ... interested investors. , , About Oxygen Biotherapeutics, ...
... , , WILMINGTON, ... ), a dermatology company that is developing and marketing Levulan(R) Photodynamic ... conditions, announced that Bob Doman, President and Chief Executive Officer, will ... Conference on Tuesday, September 29, 2009 at 10:30 a.m. ET at ...
... FALLS CHURCH, Va., Sept. 22 ... the successful implementation of the first phase of Fletcher Allen ... Record and Information Systems Management), after a 15-month planning and ... areas as well as the Emergency Department, Walk-In Care Center, ...
... have boosted seniors, sexually transmitted infection rates, researchers say ... who recently lost their wives are more likely to ... are still married, a new study has found. ... like Viagra could boost the risk, noting the widowers ...
... , Changes Reflect Provisions in NAIC Model Act ... URAC , a leading health care accreditation and education organization, ... changes to its Independent Review Organization (IRO) Standards, Version 4.1. Purchasers, policy ... to provide their comments on t he proposed URAC standards ...
... , SAN DIEGO, Sept. 22 ... a Benefit Concert for Dystonia on Saturday, October 3, 2009 at ... , , Dystonia is a devastating neurological ... in various muscle groups of the body. Some forms are focal ...
Cached Medicine News:Health News:CSC Helps Fletcher Allen Health Care Implement Phase One of Electronic Health Records System in 15 Months 2Health News:CSC Helps Fletcher Allen Health Care Implement Phase One of Electronic Health Records System in 15 Months 3Health News:Sex With New Partners Raises Widowers' Disease Risk 2Health News:URAC Open Public Comment Period for New Independent Review Organization Standards 2Health News:URAC Open Public Comment Period for New Independent Review Organization Standards 3Health News:Juice Newton Performs Benefit Concert to Support Dystonia Research 2
... unique fiberoptic laryngoscope blade that can give ... needed during difficult intubations. The articulating tip ... to be raised by squeezing a lever ... produces a more complete exposure of the ...
... laryngoscope handles can be used with Portex® ... sturdy chrome blades with long-lasting bronze fiber-optic ... for continuous routine use., ,The laryngoscope ... of sizes, from infant to large adult, ...
... handles can be used with Portex® reusable ... chrome blades with long-lasting bronze fiber-optic bundles ... continuous routine use., ,The laryngoscope blades ... sizes, from infant to large adult, and ...
... an innovative intubation system. Providing an unobstructed ... is ideal for many types of intubations., ... embedded within the patented Glidescope blade. Clear ... displayed on a monitor screen. An LED ...
Medicine Products: